Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-045907

SVP, Chief Commercial Officer gave up 6,000 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Cumbo Alexander · SVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-08 Shares withheld for taxes : show line 1 in the form −6,000 $121.02 $726,120 22,766 D
Loading xslF345X03/doc4.xml…